FUCA2
Plasma alpha-L-fucosidase
Also known as: dJ20N2.5, FUCO2_HUMAN, MGC1314
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BTY2
- Gene
- FUCA2
- Ensembl
- ENSG00000001036
- Chromosome
- 6
- Canonical length
- 467 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
This gene encodes a plasma alpha-L-fucosidase, which represents 10-20% of the total cellular fucosidase activity. The protein is a member of the glycosyl hydrolase 29 family, and catalyzes the hydrolysis of the alpha-1,6-linked fucose joined to the reducing-end N-acetylglucosamine of the carbohydrate moieties of glycoproteins. This enzyme is essential for Helicobacter pylori adhesion to human gastric cancer cells. [provided by RefSeq, Aug 2010]
Canonical amino-acid sequenceUniProt
467 residues, UniProt reviewed canonical sequence.
>Q9BTY2|FUCA2
1 MRPQELPRLA FPLLLLLLLL LPPPPCPAHS ATRFDPTWES LDARQLPAWF DQAKFGIFIH
61 WGVFSVPSFG SEWFWWYWQK EKIPKYVEFM KDNYPPSFKY EDFGPLFTAK FFNANQWADI
121 FQASGAKYIV LTSKHHEGFT LWGSEYSWNW NAIDEGPKRD IVKELEVAIR NRTDLRFGLY
181 YSLFEWFHPL FLEDESSSFH KRQFPVSKTL PELYELVNNY QPEVLWSDGD GGAPDQYWNS
241 TGFLAWLYNE SPVRGTVVTN DRWGAGSICK HGGFYTCSDR YNPGHLLPHK WENCMTIDKL
301 SWGYRREAGI SDYLTIEELV KQLVETVSCG GNLLMNIGPT LDGTISVVFE ERLRQMGSWL
361 KVNGEAIYET HTWRSQNDTV TPDVWYTSKP KEKLVYAIFL KWPTSGQLFL GHPKAILGAT
421 EVKLLGHGQP LNWISLEQNG IMVELPQLTI HQMPCKWGWA LALTNVILocalizationUniProt · AlphaFold · HPA
Whether an antibody against FUCA2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 156 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 156 nTPM
- choroid plexus: 64 nTPM
- kidney: 51 nTPM
- rectum: 50 nTPM
- liver: 49 nTPM
- placenta: 47 nTPM
Single-cell type
- extravillous trophoblasts: 158 nCPM
- decidual stromal cells: 152 nCPM
- hofbauer cells: 139 nCPM
- kupffer cells: 107 nCPM
- leydig cells: 77 nCPM
- migrating cytotrophoblasts: 76 nCPM
Immune cell
- classical monocyte: 85 nTPM
- intermediate monocyte: 84 nTPM
- myeloid DC: 65 nTPM
- non-classical monocyte: 62 nTPM
- total PBMC: 52 nTPM
- basophil: 39 nTPM
Brain region
- choroid plexus: 57 nTPM
- white matter: 39 nTPM
- medulla oblongata: 33 nTPM
- hypothalamus: 32 nTPM
- spinal cord: 31 nTPM
- thalamus: 31 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.9
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.82
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- fucose metabolic process
- glycoside catabolic process
- regulation of entry of bacterium into host cell
- response to bacterium
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FUCA2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FUCA2 as an antibody target. Whether an autoantibody or antibody against FUCA2 could matter depends on whether native FUCA2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FUCA2 is annotated as secreted, so native FUCA2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label FUCA2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...